The Advanced Materials + BioEngineering Research (AMBER) center, headquartered in Dublin, Ireland, is undertaking a project to develop 3D bioprinted implants for people suffering from osteoarthritis.
Made to regenerate rather than replace diseased joints, these implants could be an innovative solution for medical problems that affect over 900,000 people in the Republic of Ireland, and around 28.9% of the UK population alone.
Regenerate rather than replace
This project is the latest news from AMBER’s 3D bioprinting lab. With plans announced in 2018, the $4.9 million (€4.3 million) facility is the product of a collaboration between AMBER and multinational medical device and pharmaceutical company Johnson & Johnson.
In the project, the AMBER team plans to create a hybrid implant containing a titanium core. To promote regeneration, the implant will be seeded with patient tissue – presumable 3D bioprintied in the lab.
In an article in Irish Times Professor Danny Kelly, lead principal investigator on the project at AMBER, explains, “Theoretically at least we can begin to print new tissues or organs to potentially treat diseases like arthritis,”
“So instead of replacing the joint with a piece of metal we could replace it with a piece of lab-grown bone or cartilage that could regenerate that joint.”
Image Credit: Beau Jackson / 3D Printing Industry